至今,GentleGen的服务及产品已被Cell, Nature, Science, PNAS等多家生物医药类杂志引用。多家全球著名机构使用GentleGen的基因合成、寡核苷酸合成服务、抗体服务、基因编辑服务和高通量测序服务等成功地发表科研成果,再次证明GentleGen有能力帮助业内科学家.您也可以联系我们上传您的文章,获取奖励,联系链接:markerting@gentlegen.com,您发表文章中产品需要备注来自GentlGen,可获取奖励。
VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300
作者:Susu Guo , Xiaodi Hu , Jennifer L Cotton , Lifang Ma , Qi Li , Jiangtao Cui , Yongjie Wang , Ritesh P Thakare , Zhipeng Tao , Y Tony Ip , Xu Wu , Jiayi Wang , Junhao Mao
PMCID: PMC11092657 PMID: 38746415
DOI: 10.1101/2024.05.01.592016
POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma
作者:Hao Wang, Yuan Liang, Zheng Liu, Rui Zhang, Jiashuo Chao, Mingming Wang, Mu Liu, Lei Qiao, Zhengfeng Xuan, Haitao Zhao and Ling Lu,
Doi:10.1136/jitc-2023-008721